Delivery Order SPE2DB22D3009-SPE2DB25FAZ32
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Trintellix 10 mg tablets in a 30-count package, with a ceiling value of $1,538.48. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by July 16, 2025. The contract will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Trintellix 5 mg tablets (30-count unit) valued at $1,263.99. This firm fixed-price delivery order, which matures on June 27, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Trintellix 10 mg tablets (30-count) under a firm fixed-price contract valued at $4,781.16. This is a non-set-aside competitive award with an ultimate completion date of August 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,016.30 to AmerisourceBergen Drug Corp for the supply of Trintellix 5 mg tablets (30-count) on September 23, 2025, with completion scheduled for September 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trintellix 5 mg tablets (30-count) with a contract ceiling value of $4,978.44. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,878.66 to AmerisourceBergen Drug Corp for the supply of Trintellix 10 mg tablets (30-count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The order represents a small-value transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,356.39 to supply Trintellix 20 mg tablets (30-count) with a firm fixed price structure and completion date of September 22, 2025. This non-set-aside, competitively awarded contract represents a standard pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,955.35 on August 4, 2025, for the supply of Trintellix 20 mg tablets (30-count packages). This is a firm fixed-price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 5, 2025. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,673.88 to AmerisourceBergen Drug Corp for the supply of Trintellix 20 mg tablets (30-count units) on August 19, 2025, with completion targeted for August 20, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00...
- The Defense Logistics Agency awarded a $2,491.15 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Trintellix 20 mg tablets in a quantity of 30 units. This non-set-aside, competitively awarded contract features firm fixed price pricing with an ultimate completion date of September 19, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical supply...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FAZ32Delivery Order
The Defense Logistics Agency awarded a $5,667.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trintellix 5 mg tablets (30-count units) on June 12, 2025, with an ultimate completion date of June 13, 2025. The contract was not set-aside and represents a competitive award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. Performance will occur at the vendor's corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this framework, AmerisourceBergen Drug Corp provides critical pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with Trintellix—a psychiatric medication for major depressive disorder—representing one of many therapeutic products available under the contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 6/12/25 |